Financial results - LOTUS PHARMA S.R.L.

Financial Summary - Lotus Pharma S.r.l.
Unique identification code: 31120899
Registration number: J14/12/2013
Nace: 4773
Sales - Ron
1.623.459
Net Profit - Ron
49.954
Employees
11
Open Account
Company Lotus Pharma S.r.l. with Fiscal Code 31120899 recorded a turnover of 2024 of 1.623.459, with a net profit of 49.954 and having an average number of employees of 11. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Lotus Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 256.732 350.826 550.619 557.334 643.010 822.911 986.060 1.336.205 1.418.552 1.623.459
Total Income - EUR 256.762 352.930 550.647 557.337 643.149 822.987 995.084 1.363.561 1.418.591 1.638.886
Total Expenses - EUR 248.161 340.303 509.444 535.755 626.666 779.151 945.653 1.297.643 1.370.483 1.579.722
Gross Profit/Loss - EUR 8.602 12.627 41.203 21.582 16.483 43.836 49.431 65.918 48.107 59.165
Net Profit/Loss - EUR 6.799 10.016 34.382 15.971 10.009 37.307 41.055 57.137 40.222 49.954
Employees 4 5 6 7 8 9 10 12 12 11
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 15.1%, from 1.418.552 euro in the year 2023, to 1.623.459 euro in 2024. The Net Profit increased by 9.957 euro, from 40.222 euro in 2023, to 49.954 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Lotus Pharma S.r.l.

Rating financiar

Financial Rating -
LOTUS PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Lotus Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lotus Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Lotus Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lotus Pharma S.r.l. - CUI 31120899

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 6.850 19.679 32.295 25.996 16.237 47.404 98.227 81.560 74.377 95.122
Current Assets 79.373 135.282 197.386 276.055 277.645 393.268 513.183 585.023 546.669 635.410
Inventories 48.376 80.936 105.231 148.988 141.391 217.627 317.773 361.762 317.022 355.715
Receivables 29.845 36.355 84.392 101.806 103.398 139.698 171.127 196.669 210.577 251.641
Cash 1.152 17.991 7.763 25.261 32.857 35.944 24.283 26.592 19.070 28.054
Shareholders Funds 11.952 10.069 44.281 59.440 68.298 73.714 85.612 134.961 98.756 148.158
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 74.594 145.407 185.850 243.199 225.892 367.975 526.387 532.689 525.860 585.614
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 635.410 euro in 2024 which includes Inventories of 355.715 euro, Receivables of 251.641 euro and cash availability of 28.054 euro.
The company's Equity was valued at 148.158 euro, while total Liabilities amounted to 585.614 euro. Equity increased by 49.954 euro, from 98.756 euro in 2023, to 148.158 in 2024.

Risk Reports Prices

Reviews - Lotus Pharma S.r.l.

Comments - Lotus Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.